KEYNOTE 1: Use of AI and Advanced Analytics to Accelerate Drug Development
SPEAKERS: Pandurang M Kulkarni, Eli Lilly
MODERATOR: Ivan F. Chan
Abstract:
Artificial intelligence, machine learning, and advanced analytics are rapidly reshaping the way medicines are discovered, developed, and delivered to patients. In this presentation, we will discuss
- Evolving role of statistics and data science across the development continuum
- Evolution of innovation in analytical and AI capabilities to accelerate drug development
- Importance of science and statistical rigor/capabilities
Instructors’ Biography:
Dr. Pandu Kulkarni is the Chief Analytics Officer / Vice President of Biometrics and Advanced Analytics Organization leading an organization of nearly 700 people comprising of Statisticians from discovery to commercialization, Medical writing, and Data Standards and Technology.
He obtained his Ph.D. in Statistics at the LaTrobe University, Melbourne, Australia. He taught and did research in statistics at the University of South Alabama for 10 years where he attained tenure and full professorship.
He received several grants from the Air Force for the development of techniques to evaluate and study the effects of environmental contaminants such as dioxin on humans. He also received grants from NASA to study the effects of microgravity to see the effectiveness of exercise countermeasures in minimizing the effects of microgravity on astronauts.